Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank31
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P31
Within normal range
vs 5Y Ago
-1.7x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-52.13%
2024-91.75%
2023-17.84%
20229.07%
2021-22.40%
202030.97%
2019-57.59%
20182.47%
2017-48.45%
2016-0.76%